Forte Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$76.99

+0.02 (+0.03%)

As of Sep 22, 3:15 PM ET ·

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 6 55%

Hold 5 45%

Sell 0 0%

Price Target

Analyst Price Target -89.6% upside

Low Target $5.39

Average Target $7.97

High Target $9.61

Current Price $76.99

Current
$76.99

Target
$7.97

$5.39 $7.97 avg $9.61

Scenario Analysis

Bear Case

$5.39

-93.0%

Low target

Base Case

$7.97

-89.6%

Avg target

Bull Case

$9.61

+-87.5%

High target

Risk/Reward

0.9x

Unfavorable

Price in Context

52-Week High

$77.20

-0.3% from high

52-Week Low

$10.18

+656.3% from low

Target vs 52W High

$7.97

-89.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%